Komsu Mamuya, MD
Cardiovascular Disease · Wethersfield, CTNPI 1073588695
Payments from drug & device makers
Across 457 payments — averaging $54.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$13K
- Abbott$2K
- Johnson & Johnson$2K
- Novo Nordisk$1K
- E.r. Squibb & Sons, L.L.C.$1K
- Pfizer$668
- plus $5K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 81 | $12,944 |
| Abbott | 28 | $2,092 |
| Johnson & Johnson | 59 | $1,638 |
| Novo Nordisk | 26 | $1,100 |
| E.r. Squibb & Sons, L.L.C. | 48 | $1,067 |
| Pfizer | 28 | $668 |
| Novartis | 25 | $637 |
| Boston Scientific | 5 | $598 |
| Boehringer Ingelheim | 39 | $568 |
| Merck | 17 | $406 |
| Alnylam Pharmaceuticals Inc. | 8 | $347 |
| Impulse Dynamics (USA) Inc. | 3 | $255 |
| AstraZeneca | 13 | $242 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $191 |
| Bridgebio Pharma, Inc. | 3 | $180 |
| Scpharmaceuticals Inc. | 10 | $166 |
| Heartflow, Inc. | 3 | $163 |
| Actelion Pharmaceuticals US, Inc. | 7 | $159 |
| Lexicon Pharmaceuticals, Inc. | 6 | $156 |
| Bracco Diagnostics Inc. | 1 | $144 |
| Sanofi-aventis U.S. LLC | 6 | $138 |
| Lilly USA, LLC | 5 | $136 |
| Biotronik Inc. | 1 | $112 |
| Bayer | 4 | $102 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $79 |
| Esperion Therapeutics, Inc. | 3 | $67 |
| Amarin Pharma, Inc. | 4 | $64 |
| Baxter Healthcare | 1 | $46 |
| Atricure, Inc. | 1 | $30 |
| Philips North America LLC | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Angiodynamics, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $20 |
| Preventice Services, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
How this compares
$24,748 in reported general payments places this provider in the 85th percentile of 415 cardiovascular disease providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Wethersfield
- Carol Gemayel BarraWethersfield$285K
- Harlan KrumholzNew Haven$4M
- Jeffery TestaniNew Haven$3.4M
- Nihar DesaiNew Haven$3.2M
- Stuart ZarichBridgeport$1.3M
- John ForrestNew Haven$1.2M
- Hyung ChunNew Haven$1.1M
- Rohan KheraNew Haven$930K
- Brett NowlanBloomfield$798K
- Carlos Mena-HurtadoNew Haven$665K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.